What are the possible side effects of nintedanib/Vigat treatment?

Nintedanib (Nintedanib) is a multi-target tyrosine kinase inhibitor widely used in the treatment of idiopathic pulmonary fibrosis (IPF) and other progressive fibrotic lung diseases. As an oral drug, nintedanib exerts anti-fibrotic effects by inhibiting platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), and vascular endothelial growth factor receptor (VEGFR). However, like most targeted drugs, nintedanib may cause a series of side effects during treatment, which require monitoring and management by patients and doctors.

The most common side effects focus on the gastrointestinal system and include diarrhea, nausea, decreased appetite, and mild indigestion. These reactions usually appear at the beginning of treatment and can be improved by adjusting the dose, taking it in divided doses, or combining it with diet. Some patients may also experience liver function abnormalities, manifested by elevated serum aminotransferases. Therefore, liver function indicators need to be monitored regularly during the use of nintedanib in order to adjust medication in a timely manner. A small number of patients may develop thrombocytopenia or mild to moderate anemia and require follow-up blood routine.

Other potential side effects of nintedanib include rash, hair changes, headache, and fatigue, which are generally tolerated and do not affect long-term treatment. In clinical practice, doctors will adjust the dosage according to the patient's individual condition to ensure the efficacy while reducing the incidence of side effects. It should be noted that nintedanib cannot reverse existing pulmonary fibrosis, but it can provide patients with long-term survival and quality of life by delaying disease progression and reducing acute exacerbations.

Generally speaking, the side effects of nintedanib in the treatment of pulmonary fibrosis are generally controllable. Patients need to follow medical advice to regularly review liver function and blood routine, pay attention to gastrointestinal tolerance, and report abnormal symptoms in a timely manner. Reasonable management of side effects can ensure the maximum efficacy of drugs, while helping patients adhere to long-term treatment and achieve a balance between disease control and quality of life.

Reference materials:https://en.wikipedia.org/wiki/Nintedanib